Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New eczema pill shows promise over older treatment

NCT ID NCT05969730

First seen Jan 11, 2026 · Last updated May 20, 2026 · Updated 21 times

Summary

This study tested whether baricitinib (a newer pill) works better than azathioprine (an older pill) for adults with moderate-to-severe eczema. Both groups also used steroid creams. The trial involved 40 adults and measured skin improvement after 12 weeks. The goal is to find a more effective and safer option for controlling this chronic skin condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Iran

    Sari, Mazandaran, Iran

Conditions

Explore the condition pages connected to this study.